Determination of aflatoxin b1 biotransformation and binding to hepatic macromolecules in human precision liver slices

Toxicology and Applied Pharmacology

Volumn 136, Issue 1, 1996, Pages 1-7

  Heinonen, John T ^a   Fisher, Robyn ^b   Brendel, Klaus ^b   Eaton, David L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; DNA; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN TISSUE; LIVER SLICE; NONHUMAN; OXIDATION; PROTEIN BINDING; RAT; RNA BINDING; SPECIES DIFFERENCE; XENOBIOTIC METABOLISM; ADULT; AGED; ANALYSIS OF VARIANCE; ANIMAL; BINDING SITE; COMPARATIVE STUDY; CYTOLOGY; ENZYMOLOGY; FEMALE; FROZEN SECTION; LIVER; MALE; METABOLISM; OXIDATION REDUCTION REACTION;

ADULT; AFLATOXIN B1; AGED; ANALYSIS OF VARIANCE; ANIMALS; BINDING SITES; BIOTRANSFORMATION; DNA; FEMALE; FROZEN SECTIONS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; LIVER; MALE; OXIDATION-REDUCTION; RATS;

EID: 0029664692     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0001     Document Type: Article

References (54)

1. Beland, F. A., Dooley, K. L., and Casiano, D. A. (1979). Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J. Chromatogr. 174, 177-186.
2. 1 in rats. Cancer Lett. 19, 126-132.
3. Campbell, T. C., and Hayes, J. R. (1976). The role of aflatoxin metabolism in its toxic lesion. Toxicol. Appl. Pharmacol. 35, 199-222.
4. 1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: The relationship of DNA binding to carcinogenecity. Carcinogenisis 9, 711-716.
5. Conney, A. H., Pantuck, P. J., Hsaio, K. C., Garland, W. A., Anderson, K. E., Alvares, A. P., and Kappas, A. (1976). Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clin. Pharmacol. Ther. 20, 633-642.
6. Crespi, C. L., Penman, B. W., Leakey, J. A. E., Arlotto, M. P., Stark, A., Parkinson, A., Turner, T., Steimel, D. T., Rudo, K., Davies, R. L. (1990). Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11, 1293-1300.
7. Croy, R. G., and Wogan, G. N. (1981). Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys. J. Natl. Cancer Inst. 66, 761-768.
8. 1 in the rat is a glutathione conjugate. Chem.-Biol. Interact. 22, 239-255.
9. Eaton, D. L., and Gallagher, E. P. (1994). Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34, 135-172.
10. Eaton, D. L., and Ramsdell, H. S. (1991). Species and diet-related differences in aflatoxin biotransformation. In Handbook of Applied Mycology (D. Bhatnager, Ed.), pp. 157-182. Dekker, New York.
11. 1: In vitro studies in rat, mouse, monkey and human liver. In Microbial Toxins in Foods and Feeds: Cellular and Molecular Modes of Action (A. E. Pohland, V. R. J. Dowell and J. L. Richard, Eds.), pp. 275-290. Plenum, New York, London.
12. Eaton, D. L., Ramsdell, H. S., and Neal, G. E. (1994). Biotransformation of aflatoxins. In The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance (D. L. Eaton and J. D. Groopman, Eds.), pp. 45-72. Academic Press, San Diego.
13. 1 with glutathione in the rat. Xenobiotica 9, 737-743.
14. 1: Patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metab. Rev. 13, 581-602.
15. Fisher, R., Smith, P. F., Sipes, I. G., Gandolfi, A. J., Krumdieck, C. L., and Brendel, K. (1990). Toxicity of chlorobenzenes in cultured rat liver slices. In Vitro Toxicol. 3, 181-194.
16. Gallagher, E. P., Stapleton, P. L., Kunze, K. L., and Eaton, D. L. (1995). Kinetics of in vitro CYP1A2 and 3A4-mediated aflatoxin B1 oxidation in human liver. Toxicologist 15, 1395.
17. Gallagher, E. P., Wienkers, L. C., Stapleton, P. L., Kunze, K. L., and Eaton, D. L. (1994). Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Res. 54, 101-108.
18. Groopman, J. D., Cain, L. G., and Kensler, T. (1988). Aflatoxin exposure in human populations: Measurements and relationship to cancer. CRC Crit. Rev. Toxicol. 19, 113-143.
19. Groopman, J. D., Jiaqi, Z., Donahue, P. R., Pikul, A., Zhang, L., Chen, J.-S., and Wogan, G. N. (1992). Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res. 52, 45-52.
20. Guengerich, F. P., and Turvy, C. G. (1991). Comparisons of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256, 1189-1194.
21. Hall, A. J., and Wild, C. P. (1994). Epidemiology of aflatoxin-related disease. In The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance (D. L. Eaton and J. D. Groopman, Eds.), pp. 233-258. Academic Press, San Diego.
22. 1-8,9-epoxide. Biochem. J. 279, 385-398.
23. 1-S-glutathione in the rat. Xenobiotica 17, 139-153.
24. 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases. Cancer Res. 46, 3924-3931.
25. 1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis 6, 759-763.
26. 1 by normal and tumorous liver tissue from Thailand. Carcinogenesis 14, 2613-2620.
27. Krumdieck, C. L., Dos Santos, J. E., and Ho, K. (1983). A new instrument for the rapid preparation of tissue slices. Anal. Biochem. 104, 118-123.
28. Kunze, K. L., and Trager, W. F. (1993). Isoform selective mechanism-based inhibition of human cytochrome P4501A2 by furafylline. Chem. Res. Toxicol. 6, 649-656.
29. 1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 37, 4430-4438.
30. 1 in primary cultures of rat hepatocytes. J. Toxicol. Environ. Health 13, 145-159.
31. 1 hepatocarcinogenesis in the rat. Cancer Res. 47, 5218-5223.
32. 1. Proc. Natl. Acad. Sci. USA 92, 2384-2387.
33. 1 in the rat and mouse. Toxicol. Appl. Pharmacol. 90, 401-409.
34. 1 by human liver. Biochem. Pharmacol. 34, 3193-3197.
35. Peers, F., Bosch, X., Kaldor, J., Linsell, A., and Pluumen, M. (1987). Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer 39, 545-553.
36. Peers, F. G., and Linsell, C. A. (1973). Dietary aflatoxins and liver cancer -A population based study in Kenya. Br. J. Cancer 27, 473-483.
37. Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., Wogan, G. N., and Groopman, J. D. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China [see comments]. Cancer Epidemiol. Biomarkers Prev. 3, 3-10.
38. Ramsdell, H. S., and Eaton, D. L. (1990a). Mouse liver glutathione S-transferase isoenzyme activity toward aflatoxin B1-8,9-epoxide and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide. Toxicol. Appl. Pharmacol. 105, 216-225.
39. 1 carcinogenesis: Comparative kinetics of microsomal biotransformation. Cancer Res. 50, 615-620.
40. 1 by human liver microsomes: Role of cytochrome P450 IIIA enzymes. Toxicol. Appl. Pharmacol. 108, 436-447.
41. 1 exo-epoxides and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5, 470-478.
42. 1. Chem. Res. Toxicol. 5, 202-210.
43. Ross, R. K., Yuan, J. M., Yu, M. C., Wogan, G. N., Qian, G. S., Tu, J. T., Groopman, J. D., Gao, Y. T., and Henderson, B. E. (1992). Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma [see comments]. Lancet 339, 943-946.
44. Salocks, C. B., Hsieh, D. P. H., and Byard, J. L. (1984). Effects of butylated hydroxytoluene pretreatment on the metabolism and genotoxicity of aflatoxin B1 in primary cultures of adult rat hepatocytes: Selective reduction of nucleic acid binding. Toxicol. Appl. Pharmacol. 76, 498-509.
45. Schweikl, H., Taylor, J. A., Kitareewan, S., Linko, P., Nagorney, D., and Goldstein, J. A. (1993). Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3, 239-249.
46. Sesardic, D., Boobis, A. R., Edwards, R. J., and Davies, D. S. (1988). A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26, 363-372.
47. Sesardic, D., Boobis, A. R., Murray, B. P., Murray, S., Segura, J., De La Torre, R., and Davies, D. S. (1990). Furafylline is a potent and selective inhibitor of cytochrome P450 1A2 in man. Br. J. Pharmacol. 29, 651-663.
48. Shank, R. C., Bhamarapravati, N., Gordon, J. E., and Wogan, G. N. (1972). Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations of Thailand. Food Cosmet. Toxicol. 10, 171-179.
49. Smith, P. F., Gandolfi, A. J., Krumdieck, C. L., Putnam, C. F., Zukoski, I., Davis, W. M., and Brendel, K. (1985a). Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sci. 36, 1367-1365.
50. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985b). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
51. Van Rensburg, S. J., Cook Mozaffari, P., Van Schalkwyk, D. J., Van der Watt, J. J., Vincent, T. J., and Purchase, I. F. (1985). Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer 51, 713-726.
52. Wogan, G. (1973). Aflatoxin carcinogenesis. In Methods in Cancer Research (H. Busch, Ed.), pp. 309-344. Academic Press, New York/London.
53. Wrighton, S. A., Campanile, C., Thomas, P. E., Maines, S. L., Watkins, P. B., Parker, G., Mendez, P. G., Haniu, M., Shively, J. E., and Levin, W. (1986). Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol. Pharmacol. 29, 405-410.
54. Yeh, F. S., Yu, M. C., Mo, C. C., Luo, S., Tong, M. J., and Henderson, B. E. (1989). Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 49, 2506-2509.